These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18461053)

  • 1. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.
    Zhou J; Li H; Li S; Zaia J; Rossi JJ
    Mol Ther; 2008 Aug; 16(8):1481-9. PubMed ID: 18461053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
    Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
    Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
    Zhou J; Li H; Zhang J; Piotr S; Rossi J
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-targeted RNAi for HIV-1 therapy.
    Zhou J; Rossi JJ
    Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Hitchhiker's guide to HIV.
    Yan A; Ellington A
    Mol Ther; 2008 Aug; 16(8):1356-8. PubMed ID: 18660800
    [No Abstract]   [Full Text] [Related]  

  • 6. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
    Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
    Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.
    Zhou J; Swiderski P; Li H; Zhang J; Neff CP; Akkina R; Rossi JJ
    Nucleic Acids Res; 2009 May; 37(9):3094-109. PubMed ID: 19304999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge.
    Zhou J; Neff CP; Swiderski P; Li H; Smith DD; Aboellail T; Remling-Mulder L; Akkina R; Rossi JJ
    Mol Ther; 2013 Jan; 21(1):192-200. PubMed ID: 23164935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
    Zhou J; Rossi JJ; Shum KT
    Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-siRNA chimeras for HIV.
    Takahashi M; Burnett JC; Rossi JJ
    Adv Exp Med Biol; 2015; 848():211-34. PubMed ID: 25757623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.
    Zhou J; Rossi J
    J Investig Med; 2014 Oct; 62(7):914-9. PubMed ID: 25118114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice.
    Neff CP; Zhou J; Remling L; Kuruvilla J; Zhang J; Li H; Smith DD; Swiderski P; Rossi JJ; Akkina R
    Sci Transl Med; 2011 Jan; 3(66):66ra6. PubMed ID: 21248316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Selection of Gp120 ssDNA Aptamer to HIV-1.
    Sepehri Zarandi H; Behbahani M; Mohabatkar H
    SLAS Discov; 2020 Oct; 25(9):1087-1093. PubMed ID: 32452249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
    McNamara JO; Andrechek ER; Wang Y; Viles KD; Rempel RE; Gilboa E; Sullenger BA; Giangrande PH
    Nat Biotechnol; 2006 Aug; 24(8):1005-15. PubMed ID: 16823371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy.
    Pang KM; Castanotto D; Li H; Scherer L; Rossi JJ
    Nucleic Acids Res; 2018 Jan; 46(1):e6. PubMed ID: 29077949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2.
    Wullner U; Neef I; Eller A; Kleines M; Tur MK; Barth S
    Curr Cancer Drug Targets; 2008 Nov; 8(7):554-65. PubMed ID: 18991566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.
    Zhou J; Rossi JJ
    BioDrugs; 2012 Dec; 26(6):393-400. PubMed ID: 23046156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular delivery of RNA-based therapeutics using aptamers.
    Thiel KW; Giangrande PH
    Ther Deliv; 2010 Dec; 1(6):849-61. PubMed ID: 21643487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody.
    Cunha-Santos C; Perdigao PRL; Martin F; Oliveira JG; Cardoso M; Manuel A; Taveira N; Goncalves J
    Cell Mol Life Sci; 2020 Jul; 77(14):2859-2870. PubMed ID: 31641784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.